Answers are grounded in this paper and cite their sources.
Background Abdominal hysterectomy is associated with moderate-to-severe postoperative pain, and while opioids remain the primary treatment, they frequently induce opioid-associated postoperative nausea and vomiting (O-PONV). Opioid-sparing multimodal therapies are expected to mitigate this dose-dependent risk, but direct evidence comparing their emetogenic profiles remains limited and heterogeneous. To address this, a systematic review comprising both pairwise and network meta-analyses was conducted to evaluate O-PONV incidence across different analgesic strategies for abdominal hysterectomy. The risk between morphine monotherapy and morphine-based multimodal therapies was compared. Methods A systematic search of PubMed, EMBASE, the Cochrane Library, and RISS was conducted in March 2026 according to PICO-based criteria. Eligible studies were randomized controlled trials (RCTs) of patients undergoing abdominal hysterectomy that compared postoperative opioid-based analgesic regimens and reported postoperative nausea and vomiting (PONV) within 24 hours. Risk of bias was evaluated using the Cochrane RoB 2 tool. Pairwise meta-analysis estimated pooled odds ratio with 95% confidence intervals, and a frequentist network meta-analysis compared individual treatment regimens and ranked them based on P-scores. Results A total of 10 RCTs involving 711 patients were included that compared morphine monotherapy with morphine-based multimodal regimens. In the pairwise meta-analysis, multimodal therapy showed a significantly lower risk of nausea or vomiting than monotherapy (OR, 0.561; 95% CI, 0.406–0.776; P < 0.001; I² = 0%). In the network meta-analysis, morphine plus tenoxicam regimen ranked highest according to the P-score and was associated with a significantly lower risk of postoperative nausea or vomiting than morphine monotherapy and morphine plus acetaminophen. Separate analyses of postoperative nausea and postoperative vomiting also demonstrated significantly lower risks with multimodal therapy than with morphine monotherapy. Mean morphine consumption was significantly lower with multimodal therapies than with monotherapy (35.22mg vs. 44.28mg; P < 0.0001). Conclusions Compared with monotherapy, morphine-based multimodal therapies were associated with a significantly lower risk of O-PONV after abdominal hysterectomy, with morphine plus tenoxicam exhibiting the lowest risk. Further studies incorporating a broader range of recent clinical trials are warranted to reconfirm these associations and strengthen the evidence base.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: